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ABSTRACT 
Vitamin C, as a water-soluble antioxidant and vitamin E being the major lipid-soluble 
antioxidant, play vital roles in preventing oxidative damage. Flavonoids are a class of 
plant secondary metabolites well known for antioxidant activities that due to their 
amphiphilicity may interact with both vitamin C and vitamin E. This research 
investigates their cooperation with vitamin C and vitamin E on oxidative status in vitro 
using artificial liposomes and isolated rat liver mitochondrial membranes. 
Vitamin C induced pro-oxidant effects in both systems and the oxidative stress was 
positively correlated with its concentration. The presence of vitamin E in liposomes 
inhibited the pro-oxidant effect of ascorbic acid, and the flavonoid quercetin inhibited 
this effect in vitamin E-free liposomes. 
Experiments with added tert-butyl hydroperoxide were used to test for a possible 
cooperation between vitamin C, flavonoids, and vitamin E in inhibiting lipid peroxidation. 
While most of the conditions did not reveal cooperation, evidence for cooperation 
involving quercetin was observed in liposomes at the lowest level of vitamin E tested. 
In measurements of vitamin E (α-tocopherol) content in mitochondria using HPLC and 
mass spectrometry, the combination of vitamin C and quercetin was able to 
synergistically regenerate the α-tocopherol in the presence of hydroperoxide while the 
regeneration did not happen with either vitamin C or quercetin alone. However, the 
recovery of vitamin E did not relate to the TBARS measurement, indicating that the α-
tocopherol concentration was not directly correlated to the TBARS formation. 
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Based on this research, acorbate has pro-oxidative effects on both systems, which can be 
suppressed by quercetin but not completely by vitamin E. Among the tested flavonoids, 
only quercetin was observed to synergistically interact with acorbate to regenerate α- 
tocopherol, although under this condition the interaction did not rescue the mitochondria 
from oxidative damage.  
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1. INTRODUCTION 
1.1. Vitamin C 
In 1767, using the first recorded controlled experiment, James Lind established the 
scientific basis of scurvy and citrus fruits were found able to prevent scurvy. The 
antiscorbutic factor in citrus fruits was found in 1933 and named as L-ascorbic acid 
(Figure 1) by Albert Szent-Györgyi, and it was confirmed to be vitamin C. Scurvy was 
once believed to be exclusive to humans, which was proved wrong but still, the human is 
one of the few species that cannot synthesize vitamin C. The inability to synthesize 
vitamin C is due to lack of the enzyme, gulonolactone oxidase, which is essential in the 
last step of vitamin C synthesis (1). 
 
Figure 1. Vitamin C in reduced form (A, L-ascorbic acid) and oxidized form (B, 
dehydroascorbic acid, DHA). 
With accumulated research on vitamin C, more of its functions were discovered. Now it 
is believed that it has two primary functions in vivo; it works as a cofactor facilitating 
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specific enzyme actions, notably in collagen synthesis, and as an antioxidant protecting 
cells from oxidative stress (2). 
1.1.1 Absorption pathways 
Vitamin C can be taken up into cells in both oxidized and reduced forms. The oxidized 
form, dehydroascorbate (DHA), may be absorbed by two pathways, either by simple 
diffusion or by glucose transporters (GLUT) (3). The interaction between DHA and 
GLUT has been studied for years (4-6). Consistent evidence suggests that DHA in some 
tissues shares the same transporters with glucose (5, 7). There are several glucose 
transporter (GLUT) isoforms interacting with DHA, differing by their substrate affinity, 
tissue distribution, and efficiencies (3). GLUT1 and GLUT4 are the major DHA 
transporters. GLUT1 mediates the transport of DHA with a similar rate to that for glucose, 
and GLUT4 possesses a lower rate compared to glucose. GLUT2 and GLUT5 are unable 
to facilitate this process, while GLUT 3 is only able to transport the reduced form of 
ascorbate (8).  
The other cell entry pathway for DHA does not require energy and is sodium-
independent (9). Once the DHA enters the cell, it is reduced to ascorbate immediately, 
generating a gradient of DHA across the membrane (9). Chemical reduction by 
glutathione (GSH) (10) and enzymatic reduction by dehydroascorbate reductase (11) are 
two major pathways of maintaining the DHA gradient. 
The reduced form, ascorbate, is accumulated by two sodium-dependent vitamin C 
transporters (SVCT1 and SVCT2), which were cloned and characterized in 1999 (12). 
The two transporters are distributed in different locations across the body. SVCT1 is 
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more concentrated in epithelial cells of kidney, intestine and liver, which may account for 
the whole body homeostasis involving intestinal absorption and renal reabsorption, 
whereas SVCT2 is widespread in most tissues and participates in the general uptake of 
the ascorbate in most body tissues (12-14). The general cell uptake pathway is 
summarized in Figure 2. 
 
Figure 2. Cell-uptake pathways of vitamin C (adapted from (15)). 
1.1.2 Antioxidant and pro-oxidant effects 
Besides its indispensible role in the synthesis of proteins in vivo, vitamin C is also well-
known for its ability to donate electrons and hydrogen atoms, serving as an antioxidant 
(16). The main target of antioxidants is free radicals, which are mainly derived from 
reactive oxygen species (ROS) and reactive nitrogen species (RNS). Free radicals can 
react with vitamin C and be reduced to a stable state. Free radicals are not always playing 
havoc in our system, as they can also serve as signalling molecules, or second messengers. 
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The reactive side of the free radicals can lead to tissue damage and ultimately, the aging 
process. The chemical nature of free radicals is that their unpaired electrons make them 
highly reactive and they tend to abstract hydrogen atoms from adjacent molecules. There 
are two major properties making vitamin C an ideal antioxidant, the low reduction 
potentials of both ascorbate and ascorbyl radical (17), and the stability plus low reactivity 
of the intermediate radical (18). Also, ascorbate is present at relatively high concentration 
(1-3 mM) in cells (2). The oxidation-reduction cycle of ascorbate is shown in Figure 3. 
When meeting a free radical, ascorbate first donates one hydrogen atom, forming a 
semidehydroascorbic acid radical. Abstraction of a second hydrogen atom leads to the 
formation of dehydroascorbate which can be reduced to ascorbic acid by dehydroascorbic 
acid reductase using glutathione. Alternatively, two intermediate radicals can react with 
each other, yielding one oxidized and one reduced form of vitamin C (2).  
 
Figure 3. Cycle of vitamin C as an antioxidant (Adapted from S.S. Gropper (2)). 
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Like a double-edged sword, vitamin C can also act as a pro-oxidant, depending on the 
environment and conditions where the molecule is active (19-21). The mixtures of iron 
salts and ascorbate have been used for decades to stimulate free-radical oxidation of 
lipids (lipid peroxidation) in vitro. Bucher et al (22) established a Fenton reaction-like 
model of ascorbate and transition metals in initiating the lipid peroxidation. Acorbate can 
stimulate free-radical reactions under certain circumstances by reducing Fe (III) to Fe (II). 
Fe (II) reacts with hydrogen peroxide to give the highly reactive hydroxyl radical (OH 

). 
Other researchers also reported that ascorbate can be a pro-oxidant due to its ability to 
reduce transition metals (17). Lee et al. reported in Science (23) that vitamin C, even 
without the presence of catalytic iron, promoted the decomposition of lipid 
hydroperoxide to DNA-reactive electrophiles in vitro, which could lead to serious DNA 
damage.  
In in vivo studies, the pro-oxidant effect of vitamin C is still not fully understood and 
generates debate (24-35). In a prominent study reported in Nature (36), 500 mg/day 
supplements in healthy individuals showed an increase in lymphocyte DNA oxidative 
damage. In another study with human volunteers, Rehman et al (28) reported that the co-
supplementation of iron (14 mg/day ferrous sulphate) and vitamin C (60 mg/day or 260 
mg/day) caused a significant rise in DNA damage (100% higher than baseline levels), 
that returned to normal after a longer period of supplementation. Also, consistent with the 
observation in vitro that ascorbate decomposes lipid hydroperoxides to genotoxic 
aldehydes (23), 400 mg/day supplementation of vitamin C to humans produced an acute 
increase in blood levels of these aldehydes by 70% (37). However, the same amount of 
ascorbate did not affect the DNA damage level in peripheral blood mononuclear cells 
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(38). When supplemented by 500 mg/day, smoking people (who have decreased plasma 
ascorbic acid levels) were found to have an increase in plasma TBARS after two months 
of supplementation (39). However, other studies showed that vitamin C supplementation 
inhibited rather than promoted iron-dependent oxidative damage. For example, vitamin C 
deficient guinea pigs loaded with iron experienced ameliorated lipid oxidation when 
supplemented with vitamin C, while low vitamin C plus high iron status caused 
additional pathophysiological changes (32).  
Overall, the data on whether ascorbate supplementation alone induces oxidative stress in 
vivo is inconsistent and conflicting. One possibility for differences between studies might 
be in the levels of other dietary antioxidants such as vitamin E or flavonoids. In this 
thesis I investigated in vitro the abilities of α-tocopherol and different flavonoids to 
influence the pro-oxidant effect of ascorbate on lipid peroxidation, as well as to cooperate 
with ascorbate as antioxidants.  
1.2. Vitamin E 
In 1922, Evans and Bishop discovered a factor X in unprocessed food which was 
indispensible for reproduction of the rats (40). Later, with much effort invested in its 
research, this factor named vitamin E has been known for many important roles in 
sustaining our health, ranging from antioxidant property to its influence in signalling 
cascades. Vitamin E now is defined as the collective name for a set of 8 related α-, β-, γ-, 
and δ-tocopherols and tocotrienols (41), which are all fat-soluble antioxidative vitamins. 
The tocotrienols have unsaturated side chains, which are saturated in tocopherols instead. 
The tocopherols differ by the location and number of the methyl groups on the chromanol 
ring (Table 1), and their counterparts in tocotrienols share the similar structure on the 
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chromanol rings (Figure 4). Each of the tocopherols is composed of eight stereoisomers 
when derived from nonchiral chemical synthesis (termed all-rac- or dl-), while all 
naturally occurring tocopherols have the same molecular configuration [RRR, d-
tocopherols or (+)-tocopherols] in their phytyl groups (42). Although sharing many 
crucial properties, each form of vitamin E has its own unique properties, with alpha- and 
gamma- tocopherol attracting the most research interest. 
 
Tocopherols 
 
Tocotrienols 
Figure 4. Tocopherols and tocotrienols 
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Table 1. Different groups in tocopherols and tocotrienols. Tocopherols are shown in 
their naturally occurring RRR-configuration. 
 R1 R2 
α- tocopherol/tocotrienols CH3 CH3 
β- tocopherol/tocotrienols CH3 H 
γ- tocopherol/tocotrienols H CH3 
δ- tocopherol/trienols H H 
   
 
1.2.1 Vitamin E in diet 
As humans are incapable of synthesizing vitamin E, its level in our body is maintained by 
dietary intake. Foods made from vegetable oils are good sources of the vitamin E family, 
especially the ones made with full-fat content, such as salad dressings, margarine and 
peanut butter (43).  
Alpha-tocopherol is the predominant form of vitamin E, as its concentration in human 
plasma and tissues was higher than other homologues (44, 45). It can be found in food 
either from plant or animal and is the primary form of vitamin E in supplements. The 
Recommended Dietary Allowance (RDA) for vitamin E before 2000 was based on “α-
tocopherol equivalents” (46), while in the 2000 edition, the RDA for vitamin E can only 
be met by α-tocopherol and the activity of synthetic (dl) α-tocopherol is specified as half 
of the natural (d) α-tocopherol (47). Vegetable oils, including canola, olive, sunflower, 
safflower and cottonseed, are great sources of α-tocopherol. It is also stored in plants 
leaves and other green parts containing chloroplasts (43). Besides the plant sources, it is 
also in animal originated foods, especially in fat tissues (43).  
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Gamma-tocopherol is the principal vitamin E form in the US diet, being about 2.5 times 
more abundant in food than α-tocopherol (48). Its source is principally vegetable oils (49). 
This form of vitamin E is more common in plant than in animal sources. In some 
vegetables oils, such as corn and soybean oil, its concentration is significantly higher than 
that of α-tocopherol (43). Because of the widespread use of these plant products, gamma-
tocopherol represents 70% of the vitamin E consumed in the typical US diet (49). 
Even though γ-tocopherol is the predominant class of dietary vitamin E in North America 
diets, α-tocopherol is the most relevant vitamin E form for human physiology, accounting 
for the majority of this vitamin present in mammalian tissues (50). The main sources of 
beta- and delta-tocopherols are nonchloroplast regions of plants and tocotrienols are 
usually found in cereal grains and legumes (43). Other classes of vitamin E are less 
studied either due to their insignificant amounts in the diet and tissues or the biological 
function of which is not different from the two major classes.   
1.2.2 Lipid peroxidation and vitamin E 
Vitamin E, as a powerful peroxyl radical scavenger, performs its anti-oxidative property 
in a chain-breaking mechanism to prevent the lipid peroxidation chain reaction in 
membranes and in plasma lipoproteins (51). Lipid peroxidation is a typical radical chain 
reaction. This reaction is initiated by reactive oxygen species (ROS), produced as a 
byproduct of oxygen metabolism and plays essential roles in cell signaling and 
homeostasis (52). ROS deplete hydrogen atoms from bis-allylic C–H bonds in 
unsaturated lipids, forming lipid radicals (53). Lipid radicals continue to react with 
molecular oxygen yielding lipid peroxyl radicals, and initiate the propagation reaction if 
not reduced by vitamin E (Figure 5). The peroxyl radicals are not stable and tend to 
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deplete hydrogen atoms from other free lipids, forming different fatty acid radicals and 
lipid peroxides.  
L L'
H H
L L'
H
L L'
H
O O
L L'
H
OOpropagation
L L'
H H
L L'
H
L L'
H
OOH
R        RH Lipid radical
Lipid peroxyl radical
Lipid
Lipid
Lipid radical
Lipid hydroperoxide
 
Figure 5. Lipid peroxidation chain reaction. 
Vitamin E composes a tiny portion of the membrane and cannot compete with 
unsaturated lipids or oxygen in the non-specific reactions with lipid radicals to prevent 
the propagation. However, peroxyl radicals react 1000 times faster with vitamin E than 
with polyunsaturated fatty acids (54). This specific reaction reduces peroxyl radical to 
corresponding lipid hydroperoxides and oxidizes vitamin E to radicals (Figure 6), which 
are relatively stable and do not react with free oxygen. The vitamin E radicals react with 
other hydrogen donors (eg. vitamin C), returning vitamin E to the reduced state (43). If 
the radicals are not reduced, it can be further oxidized by peroxyl radicals to tocopherol 
quinones (55) and other oxidation products (56). Photo-oxidation can also generate other 
products such as dihydroxy dimer, spirodimer, R-tocopherolquinone 2,3-epoxide, R-
tocopherolquinone 5,6-epoxide, and 8a-(hydroperoxy)epoxytocopherones (57). Although 
all 8 homologues show antioxidant properties (58), the α-isomers are the most active 
scavengers among them (59). 
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Figure 6. Antioxidant effect of α-tocopherol. 
 
1.2.3 Metabolism of vitamin E in vivo 
When vitamin E is absorbed excessively in vivo, it will be excreted instead of 
accumulated like the other fat-soluble vitamins (43). Vitamin E isomers are initially ω-
oxidized by cytochrome P450s (CYPs), followed by several steps of β-oxidation, and 
then conjugated and excreted in urine (60) or bile (61). The excreted metabolites are tail-
shortened and carboxylated (Figure 7), with the same double-ring head structure derived 
from either tocopherols or tocotrienols (62). Delta- carboxyethyl hydroxychroman (δ-
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CEHC) is the first to be reported among the carboxylated metabolites (63), while α-
CEHC and γ-CEHC were later discovered and shown to be present in plasma (64). 
 
Figure 7. Metabolism of tocopherols and their corresponding tocotrienols to 
carboxyethyl-hydroxychromans (CEHC). The tocopherols and tocotrienols are 
hydroxylated by cytochrome P450s (CYPs) and further carboxylated, followed by several 
steps of β-oxidation yielding the corresponding CEHC (65). 
 
1.3. Flavonoids 
Flavonoids are a class of plant secondary metabolites and are common in our daily diets 
(Figure 8). In plants, they perform multi-functions as antioxidants, antimicrobials, 
photoreceptors, visual attractors, feeding repellants, and light screens (66). Over 4,000 
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types of flavonoids have been identified in the vascular plants and they vary in quantity 
and type due to difference in plant growth, habitats and maturity. Depending on the 
oxidation level on the heterocycle, flavonoids can be divided into several categories: 
flavones, flavonols, isoflavones, anthocyanins, flavanols, proanthocyanidins and 
flavanones (67). All of these different classes share a similar triple-ring structure (Figure 
8, quercetin as an example), with 2 aromatic rings on the sides of a heterocyclic ring.  
 
Figure 8. Flavonoid classes (in parentheses) and examples. 
The flavones and flavanones are found in citrus fruits, while the anthocyanins are 
pigments of berries and grape skins. The catechins are a well known flavonoid type of 
teas, while quercetin is a major dietary flavonoid that can be found (primarily as 
glycosides) in black and green tea, apples and onions (68).  
As the plasma levels of flavonoids are directly related to human daily dietary intake and 
their compositions in various plants differ greatly (69-71), it is urgent to evaluate the 
flavonoid sources in food as well as their health benefits.   
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1.3.1 Absorption and interaction with lipid membranes 
Prior to absorption, dietary flavonoids are released by chewing, and reacting with 
digestive juices in the gastrointestinal tract and the microorganisms of the colon. 
Predominantly present as glycoside conjugates, they can be absorbed intact in only a 
small portion in the small intestine (72). A large portion of the flavonoids undergoes 
hydrolysis by lactase phlorizin hydrolase, yielding the aglycone in the brush-border of the 
small intestine epithelial cells (73). 
Before entering the blood stream, the aglycones undergo phase II metabolism forming 
sulfate, glucuronide and/or methylated metabolites through the respective enzymes. Some 
of the metabolites may efflux back into the lumen of the small intestine. Once merging 
into the bloodstream, metabolites rapidly reach the liver, where they can be subjected to 
further phase II metabolism and conversions, and enterohepatic recirculation may result 
in some recycling back to the small intestine through bile excretion (72).  
The structural characteristics of flavonoids determine their interaction with the lipid 
membrane. The intensity of this interaction at the interface of phospholipid membranes 
correlates positively with the number of polyphenol hydroxyl groups while the influence 
on membrane structure correlates to the hydrophobicity of the molecules (74). However, 
increasing hydroxyl moieties in one molecule results in increasing hydrophilic solubility 
and reduces its ability to scavenge radicals within the membrane (75). More properties, 
such as the three dimensional structure (76) and methylation of hydroxyl groups (77) will 
also affect their interaction with lipid bilayers, and this latter characteristic of the 
flavonoids is considered as a dominating factor in reacting with membranes (77).   
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1.3.2 Antioxidant property of flavonoids 
Previous studies have demonstrated that flavonoids exhibit multiple biological activities, 
such as anti-allergenic (78), anti-viral (79), anti-inflammatory (80), and vasodilating 
actions (81). However, most interest has been focused on their antioxidant activity, which 
is due to their ability to scavenge free radicals and to reduce their formation. The general 
chemical features of flavonoids in scavenging free radicals are: 1, the phenol group which 
can donate one electron to reduce radicals; and 2, the aromatic structure which stabilizes 
the aroxyl radical by resonance (82). 
According to Halliwell and Gutteridge (83), to be a successful antioxidant, the substance 
should include functions as follows: 1, suppress ROS formation either by inhibition of 
enzymes or chelating trace elements involved in free radical production; 2, scavenge 
ROS; and 3, upregulate or protect antioxidant defenses.  
Flavonoids have been confirmed to perform all of the criteria described above. 
Flavonoids inhibit enzymes such as protein kinase C (84), lipoxygenase (85), microsomal 
monooxygenase (86), mitochondrial succinoxidase, and NADH oxidase (87), which are 
all involved in ROS generation. In addition, a number of flavonoids are able to chelate 
trace metals involved in free radical production. Free copper and iron are potential 
activators of ROS formation. Metal-catalyzed oxidation and reduction of H2O2 (the 
Fenton reaction) can result in highly aggressive hydroxyl radical generation. Copper can 
also mediate LDL oxidation (88). In regard to their radical-scavenging properties, most 
research proved that flavonoids scavenge superoxide anion radicals (89, 90), as well as 
peroxyl (91), hydroxyl  (92), alkoxyl (82), and nitric oxide (93) radicals. Concerning all 
these results, it becomes readily apparent that flavonoids are highly effective scavengers 
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of most types of oxidizing species. As for the mechanism of their antioxidant effects, 
many studies have been performed to discover the relationship between their structure 
and the ROS scavenging activity. The hypothesis established by Bors et al (82) has been 
considered as the most convincing theory. According to Bors, the major determinants for 
radical scavenging capacity are, first, the presence of a catechol group in ring B, whose 
electron donating properties are strong and is a radical target, and second, a 2,3- double 
bond conjugated with the 4-oxo group, which is responsible for electron delocalization.  
The antioxidant activity of flavonoids is not restricted to the aqueous phase, but they also 
participate in the lipid phase by their dual-phase solubility. Concerning the flavonoid-
ascorbate synergistic action, Bandy and Bechara reported (94) that, using synthesized 
liposomes in vitro, some flavonoids (epicatechin and quercetin but not rutin) allow them 
to transfer electrons from ascorbate to a hydrophobic environment and thereby mediate 
antioxidant protection to membrane-bound cytochrome c. Also in two other studies, 
flavonoid-ascorbate combination was observed to have better performance as antioxidant 
than ascorbate did alone, where ascorbate even gave pro-oxidant activity in the absence 
of flavonoids in erythrocytes and cutaneous tissue-associated cells (95, 96).   
However, flavonoids are not perfect antioxidants as they have been reported to produce 
hydrogen peroxide in common tissue culture media at a concentration of 100 μM (97). In 
another study, 24 hours administration of apple juice extract (100 μM flavonoid 
equivalency) on human colon adenocarcinoma cells (HT29) generated hydrogen peroxide 
as well, while its concentration was less than that generated by media treated with the 
extract (98). The author also pointed out that the unphysiologically high polyphenol 
concentrations were not expected in vivo (98).  
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1.4. Interactions between vitamin C, vitamin E and flavonoids 
In comparing the three types of antioxidants mentioned so far, their standard reduction 
potentials are summarized in Table 2 below. 
Table 2. Thermodynamic aspects of different free radical scavengers.  
Compound 
Reduction reactions (addition of 
electron) 
E
o
(R/RH) 
(mV) 
Reference 
Lipid hydroperoxide LOO

   →  LOOH* 1000 (54) 
Polyunsaturated lipid L

   →  LH 600 (54) 
Ascorbic acid A

 →  AH 282 (99) 
α-tocopherol α-T

   →  α-TH 500 (100) 
Quercetin Q

→ QH 330 (101) 
Rutin Rut

  →  RutH 600 (101) 
Catechin Cat

  →  CatH 570 (102) 
Cyanidin Cy

 →  CyH No source  
*
 RH = reduced organic compound (R• = corresponding radicals); LOOH = lipid peroxide; 
AH = ascorbate; α-TH = α-tocopherol; QH = quercetin; RutH = rutin; Cat = catechin; 
CyH = cyanidin. 
 
Most free radicals undergo simple first- and second-order reactions, and therefore the 
tendency of the basic electron transfer reactions is predictable. The standard reduction 
potential (E
o
) represents the tendency of a chemical species to acquire electrons and 
thereby be reduced. We can predict the electron flow by using this potential and 
determine whether certain reactions can occur. Electrons are acquired from the molecules 
with lower potential and transferred to the molecules with the higher potential. The 
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potentials of flavonoids in this research are in the same range as the other two well-
known antioxidants (vitamin C & E). All of the listed antioxidants have a lower reduction 
potential compared to the propagation step in lipid peroxidation. Therefore, theoretically 
they can all react with the lipid peroxyl radical and prevent the oxidative damage on 
lipids.  
Being the major lipid soluble antioxidant, vitamin E plays a vital role in preventing 
oxidative damage to lipids. Once oxidized to the tocopheroxyl radical, vitamin E is 
believed to be regenerated by ascorbate, which was first shown in vitro (54, 103-105) and 
then confirmed in vivo, in healthy humans (106) and smokers (107). However, there has 
been some debate about the occurrence of the interaction in vivo (108, 109), and in a 
previous pilot experiment in our laboratory, the rats supplemented with vitamin C on a 
vitamin E deficient diet did not show protection from increased susceptibility to 
erythrocyte hemolysis (unpublished results) as might be expected if vitamin C could 
efficiently regenerate vitamin E.  
Another question is what factors may help protect against the pro-oxidant activities of 
vitamin C. When vitamin E was sufficient in rats, increased oxidative stress after vitamin 
C supplementation was not observed (except non-significantly in liver) using current 
methods (TBARS, protein thiols, GSH and GSSG levels) (110). In another previous 
study, liver lipid peroxidation in rats supplemented with vitamin C was only observed at 
low levels of dietary vitamin E (111). Combining these previous results, vitamin E 
appears to be a predominant factor in protecting against pro-oxidant activities of vitamin 
C. However it did not completely protect against ascorbate-induced lipid peroxidation of 
liver homogenate, or of isolated mitochondria in vitro (110). 
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Previous results in our laboratory suggested that flavonoids may play a role in protecting 
from pro-oxidative activities of ascorbate in certain cellular compartments or at low 
levels of vitamin E. Using isolated mitochondria with a normal concentration of vitamin 
E, added flavonoid was able to completely prevent ascorbate-induced TBARS formation 
in vitro (unpublished results). Feeding studies also suggested that flavonoids (with 
adequate dietary vitamin E) inhibit a vitamin C-induced increase in the susceptibility of 
liver homogenate to in vitro peroxidation (110). 
Due to their amphiphilic solubility, we hypothesize that flavonoids would facilitate the 
vitamin E regeneration by ascorbate as a bridge between these antioxidants in two phases. 
In support of this hypothesis, flavonoids alone have previously been found to spare 
vitamin E in vitro (112, 113) and in vivo (111). 
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2. HYPOTHESES AND OBJECTIVES 
2.1. Hypotheses 
The overall hypothesis is that flavonoids, vitamin E and ascorbate interact synergistically 
with each other in preventing oxidative stress. It can be divided into two parts:  
1) flavonoids and vitamin E reduce the pro-oxidant effects of vitamin C; and  
2) flavonoids and vitamin C cooperate to regenerate vitamin E and inhibit oxidative 
damage to membranes. 
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2.2. Objectives 
The research addressed four main questions:  
1) whether the presence of vitamin E in liposomes would reverse the role of vitamin C as 
a pro-oxidant; 
2) the extent to which different flavonoids (quercetin, rutin, catechin and cyanidin) can 
inhibit liposomal lipid peroxidation induced by vitamin C in the absence of vitamin E; 
3) the extent to which the different flavonoids cooperate with vitamins C and E to inhibit 
lipid peroxidation of liposomes and rat liver mitochondria synergistically; 
4) the extent to which the different flavonoids plus ascorbate work synergistically to 
regenerate and thereby spare vitamin E in rat liver mitochondria. 
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3. MATERIALS AND METHODS 
3.1. Experimental design 
The ability of flavonoids and α-tocopherol to inhibit the pro-oxidant and facilitate the 
antioxidant activities of ascorbate were studied in vitro using liposomes and 
mitochondrial membranes. Liposomes were used as a model membrane system where the 
α-tocopherol content could be manipulated. The three types of lipid 
(phosphatidylethanolamine, cardiolipin, phosphatidylcholine) selected in the liposome 
synthesis are the major components of mitochondrial membranes (114), which form a 
relatively comparable model with mitochondria. Mitochondria (from rat liver) were 
studied as an intact biologically-relevant membrane system where the interactions of 
ascorbate, flavonoids and vitamin E may be important to protection against oxidative 
stress. Mitochondria are a primary site of redox reactions in cells, which makes them 
susceptible to oxidative damage. With both systems, TBARS was used as an index of 
oxidative damage. With mitochondria, the endogenous alpha- and gamma-tocopherol 
contents were measured by HPLC and mass spectrometry.  
The ability of different flavonoids to inhibit the pro-oxidant effect of ascorbate were 
studied in both membrane systems, and the ability of α-tocopherol to inhibit was studied 
with the liposomes. The pro-oxidant effects of ascorbate were studied in the absence of 
added metals, so only involved endogenous metals (such as in cytochrome c and other 
metalloproteins).  
The ability of ascorbate, flavonoids and α-tocopherol to cooperate as antioxidants was 
studied in both membrane systems using tert-butyl hydroperoxide as the oxidant. The 
cooperative ability to regenerate or preserve α-tocopherol was studied with the 
mitochondrial membranes (as the more biologically complete system). 
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The flavonoids chosen for study were quercetin and rutin (flavonols), (+)-catechin (a 
flavanol) and cyanidin (an anthocyanin). These are all 2’3’-dihydroxy flavonoids from 
different classes, with rutin being a representative glycoside. A previous study (94) 
identified quercetin and catechin as flavonoids with the potential to cooperate with 
ascorbate to protect membranes, and rutin as a flavonoid that was unlikely to cooperate in 
this activity. 
The concentrations of ascorbate that were used (200 and 400 M) are those that can be 
achieved in blood with supplementation (100 and 250 M) (115), and near that normally 
in cells (1-2 mM) (2). The concentration of flavonoids used (50 M) was within the 
range (23-107 M) observed in plasma of rats supplemented with quercetin (116). The 
concentration of flavonoid used therefore is lower than that of ascorbate, consistent with 
the flavonoid serving as a redox intermediate in the antioxidant chain. 
3.2. Materials 
All the materials used in the research are listed in the following table, and their names 
presented in this report are in the left column. All aqueous solutions were made with 
water that was first filtered and distilled and then purified with a MilliQ 18M 
purification system. 
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Table 3. List of materials used in the research (including abbreviations). 
Name 
/Abbreviat
ion 
Full description 
PC phosphatidylcholine, Sigma XIII E, 100mg/ml, P42791 
PE phosphatidylethanolamine, Sigma III egg yolk 125mg/ml in CHCl3 P7943 
CL cardiolipin, Sigma, 4.7mg/ml, C1649 
Vitamin E approx. 670 mg d-α-tocopherol per gram. The non-α content is 5-20 mg/g; 
remainder is soybean oil, Sigma, T3634 
α-T dl-all-rac-α-tocopherol, Sigma, synthetic, ≥96%, (HPLC), T3251 
γ-T (R,R,R)-γ-tocopherol, Sigma, ≥96%, (HPLC), T1782 
Quer quercetin dihydrate, Sigma, Q0125 
Catechin (+)-catechin hydrate, Sigma, C1251 
TBA 2-thiobarbituric acid, Sigma, T5500 
SDS sodium dodecyl sulfate, Sigma, L3771 
BHT butylated hydroxytoluene, Sigma, B1378 
Acetic acid acetic acid, EMD, AX0073-59 
t-buOOH tert-butyl hydroperoxide, Sigma, 70% in water, B2633 
Asc l-ascorbic acid, Sigma BioXtra, ≥99.0%, crystalline, A5960 
HEPES 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, Sigma, ≥99.5%, 
(titration), H3375 
Vitamin K1 
Sigma-Aldrich, BioXtra, ≥99.0% , (sum of isomers, HPLC), mixture of 
isomers 
Methanol Sigma-Aldrich, CHROMASOLV®, for HPLC, ≥99.9% 
n-Hexane EMD, HX0290-1  Hexanes, HPLC, 98.5% 
Butanol EMD, BX1780-5, 1-Butanol, 99.4% 
Pyridine EMD, B10225-74, Pyridine, ANALAR 
Formic acid EMD Chemicals, Formic Acid, ACS Grade, 98, Model FX0440-5 
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3.3. Liposome preparation  
All the lipids for liposome (Lipo) preparation were mixed together in the absence of 
oxygen. To remove oxygen, solvents and solutions were saturated with N2 by bubbling 
with pure N2 for 10 min. To prepare liposomes first, 48 µl of the 
phosphatidylethanolamine solution (125 mg/ml, in N2-saturated chloroform), 950 µl of 
cardiolipin (4.7 mg/ml, in N2-saturated ethanol) and 75 µl of the phosphatidylcholine 
(100 mg/ml, in N2-saturated ethanol) were added into a test tube. The original lipid 
container was re-flushed with N2 after transferring lipids. For the vitamin E integrated 
liposomes (LipoE), α-tocopherol was diluted in N2-saturated ethanol and added into the 
tube in different amounts. After the lipids, 3 ml of chloroform was added into the tube to 
dilute and distribute the lipids. After mixing the chloroform and lipids together, N2 was 
blown into the angled and rotated tube to evaporate the solution and create a film. The 
tube was sealed with parafilm and it was frozen overnight. Before sonicating the lipids, 
3.5 ml of N2-saturated, cold 10 mM HEPES, 5 mM KPi buffer (pH 7.2) was added into 
the tube. The solution, on ice, was sonicated with the microtip probe at 50% amplitude 
(~100 Watts), for 8 X 15 second bursts with 45 seconds cool-down in between. This 
sonication changed the suspension from a cloudy opaque appearance to a more 
transparent appearance. The sonicated solution was centrifuged at 5000 g, 4 
o
C, for 20 
minutes and any pelleted material (very little was visible) was discarded. Various 
concentrations of α-tocopherol were integrated into liposome (Table 4) in order to 
determine the optimal concentration to cooperate with acorbate and flavonoids, and also 
to compare with that of mitochondria. 
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Table 4. Concentrations of α-tocopherol integrated into liposome 
Total α-tocopherol Total lipid α-tocopherol concentration 
0.0252 mg 18 mg 0.0014 mg/mg 
0.0504 mg 18 mg 0.0028 mg/mg 
0.252 mg 18 mg 0.014 mg/mg 
0.504 mg 18 mg 0.028 mg/mg 
1.512 mg 18 mg 0.072 mg/mg 
 
3.4. Mitochondria preparation 
The Animal Care Protocol (#20030012) was approved by the University of Saskatchewan 
UCACS Protocol Review Committee. The mitochondria were prepared from the livers of 
adult male Wistar rats from the University of Saskatchewan Animal Resource Centre. All 
rats in the mitochondria study were from the same age group (body weight range: 250-
350 g). The rats were decapitated after being anesthetized with isoflurane and livers were 
immediately excised and homogenized in mitochondrial preparation buffer 1 (250 mM 
sucrose, 10 mM Hepes, 1mM EGTA, pH 7.2). The mitochondria were isolated by 
differential centrifugation (117) and resuspended in buffer 3 (250 mM sucrose, 10 mM 
Hepes, pH 7.2). The mitochondria were frozen at -80
o
C for later experiments on lipid 
peroxidation and vitamin E content. 
3.5. Protein concentration measurement 
Protein concentrations of the mitochondria preparations were measured by the Biuret 
method (118). The biuret reagent is made of 32 mM potassium sodium tartrate, 12 mM 
copper sulfate, 30 mM potassium iodide, and 0.2 M NaOH, whose combination will turn 
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violet with the presence of the protein. A 100 μl aliquot of freshly extracted, or thawed-
resuspended mitochondrial samples were added into the 900 μl of the biuret reagent, 
vortexed and left for 20 minutes at room temperature and the absorbance read at 550 nm 
by spectrophotometer. Bovine serum albumin was used as a protein standard at 0, 10, 20 
40 and 80 mg/ml with 5 replicates. 
3.6. Ascorbate decay test 
In order to determine whether ascorbate was present through the incubation of liposomes 
with t-buOOH, the loss of ascorbate was monitored spectrophotometrically at 265 nm in 
50 mM KPi buffer (pH 7.2) at 37
o
C. The conditions were the same as the control groups 
in the liposomes TBARS test (50 mM KPi buffer, pH 7.2 at 37
o
C).  
3.7. Thiobarbituric acid reactive substances assay (Liposomes) 
For experiments on the effects of ascorbate and flavonoids on liposomal lipid 
peroxidation, 50 μl of lipo or lipoE was added into 200 μl of 50 mM KPi buffer, pH 7.2 
with different treatments. All the samples were vortexed and incubated at 37°C for the 
times indicated.  
This method determines levels of reactive aldehydes such as malondialdehyde (MDA), a 
lipid oxidation product, by heating the samples in the presence of thiobarbituric acid 
(TBA) at low pH, resulting in the formation of a pink chromophore with an absorption 
maximum near 532 nm (119). We modified some details of the essay. From the 
incubations, 100 μl of the incubant was added to 400 μl of thiobarbituric acid solution 
containing 9.3% acetic acid (pH 3.5), 0.5% sodium dodecyl sulfate, 0.375% 
thiobarbituric acid, and 0.0002% butylated hydroxytoluene, and heated for 1 h at 95°C. 
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The heated samples were cooled and the TBA reaction products were extracted with an 
equal volume of the butanol/pyridine (15 : 1, v:v). The mixture was centrifuged at 4000 g 
for 10 minutes, and the fluorescence of the upper layer was measured at 530 nm 
(excitation of 485 nm). MDA stock solution (10 mM) was prepared by 96.5% sulfuric 
acid and further diluted with water to obtain final concentration of 0.1mM. A series of 
concentrations were used as standards for each batch of TBA.  
The α-tocopherol content in mitochondria was fixed, while we could manipulate its 
concentration in liposomes. A series of concentrations of α-tocopherol were used to study 
its cooperation with ascorbate and flavonoids. The combinations tested were as follows 
(Table 5):  
Table 5. Tested combinations of antioxidants using liposomes 
α-tocopherol Ascorbic acid 
Flavonoids 
Quercetin Catechin Rutin Cyanidin 
0.0014 mg/mg or      
0.0028 mg/mg or 200 µM 100 µM 100 µM   
0.014 mg/mg or or or or 50 µM 50 µM 
0.028 mg/mg or 400 µM 50 µM 50 µM   
0.072 mg/mg      
Note: The combination of α-tocopherol (5 concentrations), ascorbic acid (2 
concentrations) and each type of flavonoids (2 or 1 concentration) was studied, but not 
the combination of different types of flavonoid. Each combination contained at least one 
experiment (with at least 3 replicates), and some results were not shown in the thesis. 
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3.8. Thiobarbituric acid reactive substances assay (Mitochondria) 
The basic experimental setup was the same as the TBARS test for liposomes, except as 
specified below. Thawed mitochondria suspensions were centrifuged at 12,000 g, 4
o
C, to 
remove the buffer containing sucrose, as it interferes with the TBARS results, and the 
pellet was resuspended in the same volume of 1.15% KCl. This suspension was added 
into 50mM KPi buffer (pH 7.2) to reach the final protein concentration together with 
different treatments.  
In order to compare with the liposome studies, the combinations in Table 5 were also 
repeated in mitochondria, but only with fixed α-tocopherol content (self-integrated in 
mitochondria). In addition, 100 µM of rutin and cyanidin were also tested in combination 
with 200 µM & 400 µM ascorbic acid.  
Since α-tocopherol was integrated in mitochondria, we applied the combination of 
acorbate and flavonoids in this system to investigate their influence on α-tocopherol 
content. All the samples were vortexed and incubated at 37°C for exactly 60 minutes. 
Aliquots of 100 µl were taken for measurements of TBARS, and in the experiments 
involving LC/MS analysis of α-tocopherol, the rest of the incubant (9.9 ml from 10 ml) 
was collected to extract α-tocopherol in the mitochondrial membranes (extraction method 
in the next section).  
3.9. HPLC-MS/MS analysis in measuring mitochondrial α-tocopherol 
The incubated samples were centrifuged at 12,000 g to collect the mitochondria. After 
centrifugation, the supernatant was carefully removed by Pasteur pipette and 20 µl of 300 
pM internal standard (vitamin K1) was added into the samples. In order to extract both α-
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tocopherol and internal standard, 1 ml of n-hexane:methanol (5:2) was added into the 
centrifuge tube and the pellet attached to the wall was washed off by pipettor. The 
samples were further vortexed for 1 minute, centrifuged at 150g for 1min and the upper 
n-hexane layer was carefully transferred to glass tubes. The extraction was repeated 
another two times. All the n-hexane samples collected were put into a freeze dryer 
overnight and the extract powder was redissolved in 200 µl of mobile phase and filtered 
with a 0.2 µm PTFE filter before LC/MS analysis. Under these conditions, the analytes 
were stable with over 85% recoveries. 
HPLC grade α-tocopherol and vitamin K1 were purchased from Sigma-Aldrich and 
dissolved in mobile phase separately, to 375 nM and 125 nM, as stock solutions. Four 
concentrations of α-tocopherol were further diluted to standard samples as listed in Table 
6, and analyzed by HPLC-tandem mass spectrometry. The Lower Limit of Quantification 
(LLOQ) of α-tocopherol was determined as 20 pM, at which concentration yielded peak 
heights 10 times higher than the noise baseline. 
Table 6. Analyte concentrations in the standard curve 
 α-tocopherol Vitamin K1 
Blank 0 0 
Double Blank 0 30 pM 
Standard 1 20 pM 30 pM 
Standard 2 100 pM 30 pM 
Standard 3 500 pM 30 pM 
Standard 4 1 nM 30 pM 
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Tandem mass spectrometry with an HPLC system was used to quantify the α-tocopherol 
in rat liver mitochondria. HPLC separation of α-tocopherol was achieved on a Varian 
Pursuit column (Varian Pursuit XRS, 5 micron C18, 250 mm x 3.0 mm column) using an 
Agilent 1100 HPLC system. Mobile phase A was Milli-Q water with 0.1% formic acid, 
mobile phase B was methanol with 0.1% formic acid. They were filtered through a 0.45 
µm membrane filter prior to analysis. The mobile phase was pumped at 0.8 mL/min for 
30 minutes per injection with an isocratic proportion of 0.5% A and 99.5% B.  The 
column temperature was held constant at 30°C and the sample injection volume was 10 
µL for all injections. 
MS/MS analysis was performed on a Qtrap 4000 triple quadrupole mass spectrometer 
(Applied Biosystems/MDS Sciex, Foster City, CA, USA) equipped with a heated 
nebulizer inlet (APCI). The APCI source operated in positive ion mode, and the 
following settings were used: corona discharge current, 4.0 A; source temperature, 
400°C; collision-activated collision gas (nitrogen) setting, 6 (arbitrary units); curtain gas 
(nitrogen) setting, 6; and nebulizer gas (nitrogen) setting, 10. MRM measurements with 
the transitions APCI-MS (+) m/z (431.3 165.1) for α-tocopherol and 451.3 187.3 for 
vitamin K1 were determined using declustering potential, entrance potential, collision 
energy, and collision cell exit potential values at 66 V, 10 V, 27 eV, 12 V and 71 V, 10 
V, 31 eV, 14 V respectively. The parent-daughter ion pairs are summarized in the table & 
figure below. 
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Table 7. List of molecular weight (MW), observed molecular ion (Q1), fragment ion 
(Q3), and characteristic neutral loss of different analytes under positive APCI condition 
Analyte MW[Da] Q1 m/z Q3 m/z Characteristic mass loss [Da] 
α-tocopherol 430 431 165 266 
Vitamin K1 450.7 451.5 187.1 264 
 
 
Figure 9. The daughter ions of α-tocopherol (A) and vitamin K1 (B). Mass over charge 
ratio for A, 165; B, 187.3. 
Before MS was applied, we tried using HPLC with fluorescence detection to determine 
the α-tocopherol content in the mitochondria. However, due to low sensitivity and 
specificity, the method was abandoned. Also, we tried to measure the γ-tocopherol 
content in the mitochondria with the tandem MS, as γ-tocopherol is the most abundant 
source of vitamin E in the North American diet (48, 120), and it also exists in the 
mitochondrial lipid membrane system (121). The combined concentration of α- and γ-
tocopherol would generate a bigger picture of the vitamin E status in the mitochondria 
membrane system. Although we optimized the parameters for its analysis and established 
the methods with a standard curve and LLOQ, the amount of γ-tocopherol was lower than 
the lowest quantitative amount. These results are shown in Appendix 1. 
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3.10. Statistical Analysis 
Descriptive statistical analyses were performed using Excel software (Microsoft Office 
2007) for the means and the standard error of the mean (SEM). Results were expressed as 
the mean ± SEM (or mean ± SD when only one liposome preparation was tested). The 
significance level was set at p less than 0.05. Using SPSS software for Windows (version 
19) the data were analyzed by one-way analysis of variance (ANOVA). Differences 
among treatment and control groups were determined by the multiple range post hoc test, 
Tukey’s Honestly Significant Differences (HSD). Interactive effect was determined by 
two-way ANOVA. When the p value of factor A*B was less than 0.05, an interaction of 
factor A and B was reported. Pearson correlation coefficient was computed by SPSS to 
assess the relationship between the amount of α-tocopherol integrated in liposomes and 
TBARS formation. Pearson’s correlation (r) and corresponding p value were reported as 
well. 
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4. RESULTS 
4.1. Pro-oxidant effect of ascorbate 
4.1.1. Pro-oxidant effect of ascorbate on liposomes 
In order to confirm the pro-oxidant effect of ascorbate in the liposome model, different 
levels of ascorbate were added alone to vitamin E integrated liposome. With increasing 
concentration of ascorbate added into the incubation, the TBARS generation increased 
accordingly. Ascorbate at 400 µM was able to elevate the liposomal oxidative status to a 
significant level, while 200 µM of ascorbate did not make a statistical difference 
compared to the control group (Figure 10).  
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Figure 10. TBARS generation in α-tocopherol integrated liposomes treated with different 
amounts of ascorbic acid. Liposomes were incubated in 50 mM potassium phosphate 
buffer (pH 7.2) at 37
o
C for 1 hour under different conditions (α-tocopherol 0.014 mg/mg 
in total lipids), asc – ascorbic acid 200 µM/ 400 µM, n=3 preparations). ab Different 
letters show significant differences by one-way ANOVA (post-hoc by Tukey’s HSD) at 
p<0.05. 
 
4.1.2 Pro-oxidant effect of ascorbate on rat liver mitochondria  
To investigate whether ascorbate was able to induce a pro-oxidant effect on mitochondria 
in vitro, different concentrations of ascorbate were incubated with mitochondria. The 
TBARS formation significantly increased with the presence of the ascorbate and this 
trend was enhanced by its higher concentration (Figure 11).  
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Figure 11. Pro-oxidant effect of ascorbic acid on mitochondria. Liposomes were 
incubated in 50 mM potassium phosphate buffer (pH 7.2) at 37
o
C for 1 hour under 
different conditions (α-tocopherol 0.014 mg/mg in total lipids), Asc – ascorbic acid 200 
µM/ 400 µM, n=3 preparations). 
abc
 Different letters show significant differences by one-
way ANOVA (post-hoc by Tukey’s HSD) at p<0.05. 
 
4.1.3 Limitation of pro-oxidant effect of ascorbate in liposomes by quercetin 
The ability to reduce the pro-oxidant effect of ascorbate by quercetin was tested by the 
TBARS test in liposomes without vitamin E (Figure 12). Adding 50 M quercetin alone 
had no significant effect on the liposome oxidation status. In the presence of ascorbate, 
further addition of quercetin was able to bring down the TBARS formation significantly, 
indicating that quercetin was efficient in suppressing the pro-oxidant effect of ascorbate.  
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Figure 12. TBARS generation in liposomes under treatment of ascorbic acid and 
quercetin. Liposomes were incubated in 50 mM potassium phosphate buffer (pH 7.2) at 
37
o
C for 1 hour under different conditions, Asc – ascorbic acid 200 µM, Quer – quercetin 
50 µM, n=3 preparations).  
ab
 Different letters show significant differences by one-way 
ANOVA (post-hoc by Tukey’s HSD) at p<0.05). 
 
4.2. Effects of different flavonoids, ascorbate and vitamin E in t-buOOH-
induced TBARS 
4.2.1. Ascorbate content during incubation 
The ascorbate decay test was performed to determine how long ascorbate was present 
during the incubation and the minimum initial concentration to ensure its presence during 
the one-hour incubation for TBARS experiments. After adding ascorbate (final 
concentration 200 µM) into the suspension of liposomes without α-tocopherol (Figure 
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13A), the absorbance went up to 2.5 and upon addition of peroxide, the value dropped 
quickly. At 27 minutes, the reading was stable at about 1.5. To verify whether ascorbate 
was all consumed, 10 M Cu2+ were added due to its ability to catalyze ascorbate 
oxidation by oxygen, and the value did not drop any further. The remaining absorbance 
was presumably due to lipids and peroxide-induced formation of conjugated dienes (with 
λmax = 235 nm) (122). We could conclude that the ascorbate is all oxidized after 20 
minutes of incubation with t-buOOH under these conditions. In Figure 13B, when adding 
ascorbate into the suspension of liposomes with α-tocopherol, the presence of ascorbate 
was extended and was not significantly consumed after 30 minutes incubation with t-
buOOH until adding Cu
2+
 (Figure 13B).  
As 200 µM of ascorbate was consumed in less than one hour incubation, I doubled the 
concentration and measured again. Figure 14A and B showed that in both types of 
liposomes, the 400 µM of ascorbate was able to last through one hour of incubation. 
Therefore, this concentration was chosen for the later TBARS analysis. 
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Figure 13. Peroxide-induced loss of 200 M ascorbic acid in the presence of liposomes. 
Ascorbic acid (Asc, 200 µM, t-buOOH, 1 mM, Cu
2+
, 10 µM).  A. Liposomes without α-
tocopherol. B. Liposomes with 0.072 mg/mg of α-tocopherol in total lipids. Loss of 
ascorbate was monitored spectrophotometrically at 265 nm in 50 mM potassium 
phosphate buffer (pH 7.2) at 37
o
C with additions of liposomes (18 mg/ml) total lipids), 
ascorbic acid (Asc, 200 µM), tert-butyl hydroperoxide (t-buOOH – 1 mM) and CuSO4 
(Cu
2+
, 10 µM) as indicated. 
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Figure 14. Peroxide-induced loss of 400 M ascorbic acid in the presence of liposomes, 
A. Liposomes without α-tocopherol. B. Liposomes with 0.072 mg/mg of α-tocopherol in 
total lipids. Measurements were conducted in the same condition as in the previous 
figure. Loss of ascorbic acid was monitored spectrophotometrically at 265 nm in 50 mM 
potassium phosphate buffer (pH 7.2) at 37
o
C with additions of liposomes (18 mg/ml) 
total lipids), ascorbic acid (Asc, 400 µM), tert-butyl hydroperoxide (t-buOOH – 1 mM) 
and CuSO4 (Cu
2+
, 10 µM) as indicated. In these cases the measurements were conducted 
with 0.5 cm path length cuvettes and the absorbance values were doubled to give the 
theoretical absorbance at 1 cm path length. 
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4.2.2 Effects of different flavonoids, ascorbate and vitamin E in liposomal TBARS 
In addition to quercetin, I explored (liposome with α-tocopherol concentration 0.072 
mg/mg lipids) other flavonoids from several classes: rutin (quercetin glycoside), catechin 
(flavonol) and cyanidin (anthocyanidin). The following results compared the relative 
abilities of different flavonoids to cooperate with ascorbate and vitamin E in preventing 
TBARS formation. Without the presence of the α-tocopherol, the flavonoids alone could 
not establish any protection (Figure 15). In the presence of ascorbate, only quercetin was 
able to bring down the TBARS generation to a significant level with the p value of 0.015 
(one-way ANOVA) comparing to the DMSO group (used in the quercetin stock 
solution). Notably however, t-buOOH did not increase the TBARS significantly, as the 
control liposomes already had a high level of TBARS in this preparation. Also, ascorbate 
did not increase t-buOOH-induced TBARS in this experiment with vitamin E-absent 
liposomes as was observed with some preparations (results not shown). 
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Figure 15. Effects of different flavonoids and ascorbate on TBARS generation in 
liposomes without α-tocopherol. Liposomes were incubated in 50 mM potassium 
phosphate buffer (pH 7.2) at 37
o
C for 1 hour under different conditions, (Quer- quercetin; 
Rutin; Cya – cyanidin; Catechin 50 µM) Bars represent means  SD of n=3 replicate 
incubations from one liposome preparation. 
*
 Star shows significant differences tested by 
one-way ANOVA (post-hoc by Tukey’s HSD) at p<0.05. 
With the presence of vitamin E (0.072 mg/mg lipids), the baseline TBARS was 
significantly lower than observed in liposomes without vitamin E (Figure 16 versus 
Figure 15), indicating that vitamin E was preventing lipid auto-oxidation during the 
liposome preparation. In incubations of these vitamin E-containing liposomes with t-
buOOH, flavonoids were not able to protect the liposomes either with the presence or the 
absence of ascorbate (Figure 16).  
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Figure 16. Effects of different flavonoids and ascorbic acid on TBARS generation in 
liposomes with 0.072 mg/mg α-tocopherol. Alpha-tocopherol-containing liposomes were 
incubated in 50 mM potassium phosphate buffer (pH 7.2) at 37
o
C for 1 hour under 
different conditions, (Quer- quercetin, Rutin, Cya – cyanidin and Catechin 50 µM; n=3 
preparations). 
Utilization of the liposome system allows us to integrate different levels of vitamin E into 
the lipid membrane. Hypothetically, the antioxidant property of flavonoids may perform 
better when vitamin E is insufficient. If the amount of vitamin E could not prevent the 
oxidation of relatively larger amount of lipids, then cooperation with the hydrophilic 
antioxidants can be helpful in regenerating vitamin E and sustain the protection within 
the lipid membrane. However, in experiments with α-tocopherol at 0.0028 mg/mg lipid, 
the expected synergism was again not observed (Figure 17). Due to the apparent pro-
oxidant effect of vitamin E (discussed later), the baseline TBARS level (liposomes 
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without t-buOOH) was lower compared to the results of higher vitamin E content 
liposomes (Figure 17 versus Figure 16). Similar to the results from high vitamin E 
liposomes, adding ascorbate into the samples during incubation with peroxide does not 
affect the lipid peroxidation. With peroxide, the liposomes were consistently oxidized to 
a low level (~2 M MDA equivalents) through all the treatment groups, regardless of 
presence of ascorbate or flavonoids.  
 
Figure 17. Effects of different flavonoids and ascorbic acid on TBARS generation in 
liposomes with 0.0028 mg α-tocopherol/mg lipid. Alpha-tocopherol-containing liposomes 
were incubated in 50 mM potassium phosphate buffer (pH 7.2) at 37
o
C for 1 hour under 
different conditions, (Quer- quercetin, Rutin, Cya – cyanidin and Catechin 50 µM; n=4 
repeats in one preparation of liposomes). 
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We also tested for the synergism in the presence of cytochrome c to determine whether 
its presence would induce synergism by enhancing the peroxidation process (Figure 18). 
The cytochrome c accelerated oxidation but did not induce synergism. 
 
Figure 18. Effects of ascorbic acid, quercetin and vitamin E on cytochrome c-catalyzed 
TBARS generation. Liposomes were incubated for 1 hour in 50 mM potassium phosphate 
buffer (pH 7.2) at 37
o
C with the presence of 20 µM cytochrome c in different conditions 
(α-tocopherol 0.028 mg/mg in total lipids), CytC – cytochrome c 20 µM, Asc – ascorbic 
acid 200 µM, n=3 repeats in one preparation of liposomes). 
According to previous results showing synergism with ascorbate in transmitting 
protection to a membrane environment (94), quercetin was a good candidate in 
synergistically regenerating vitamin E with ascorbate. Therefore, a large amount of time 
has been spent on searching the optimal conditions. In Table 8, all tested combinations of 
treatments are summarized and there was no synergistic protection on the liposomes (data 
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not shown in the thesis) except an additive protection by ascorbate (400 µM) and 
quercetin (100 µM) at the lowest α-tocopherol level (0.0014 mg/mg lipid) (Figure 19). 
Table 8. List of combination of different concentrations of α-tocopherol, ascorbic acid 
and quercetin in TBARS tests of liposomes undergoing t-buOOH-induced lipid 
peroxidation. 
α-tocopherol/total Lipids Asc Quer 
0.0014 mg/mg 200 µM 100 uM 
0.0014 mg/mg 400 µM 100 uM 
0.0028 mg/mg 200 µM 50 uM 
0.0028 mg/mg 400 µM 50 uM 
0.0028 mg/mg 200 µM 100 µM 
0.0028 mg/mg 400 µM 100 µM 
0.014 mg/mg 200 µM 50 µM 
0.014 mg/mg 400 µM 50 µM 
0.014 mg/mg 200 µM 100 µM 
0.014 mg/mg 400 µM 100 µM 
0.028 mg/mg 200 µM 50 µM 
0.072 mg/mg 200 µM 50 µM 
0.072 mg/mg 400 µM 50 µM 
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Figure 19. Cooperative protection from ascorbic acid and quercetin on α-tocopherol 
integrated liposomes. Liposomes were incubated with KPi buffer (pH 7.2, 50 mM) for 
one hour (α-tocopherol 0.0014 mg/mg in total lipids, Asc – ascorbic acid 400 µM, Quer – 
quercetin 100 µM, n=3 preparations with double measurements for each preparation). 
Bars represent mean  SEM. ab Different letters show significant differences by one-way 
ANOVA (post-hoc by Tukey’s HSD) at p<0.05.  
The TBARS formation in the group protected by both ascorbate and quercetin was lower 
than the groups treated with either of them, and also lower than the group treated with 
peroxide alone. Although there was no significant decrease in oxidation level by this 
antioxidant team, their combination was still able to bring down the oxidative stress level 
to which there was no longer significant difference from the baseline groups. 
Although we tried different methods to reduce the baseline TBARS in the liposomes after 
sonication, including flushing nitrogen into the buffer before and after preparation, 
keeping everything on ice through the process, separating the sonication with a cool-
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down period and centrifuging out the oversized liposomes after sonication, the liposomes 
without any treatment still had inconsistent and often elevated TBARS. In most 
preparations, the application of peroxide did not bring up the oxidation significantly, 
indicating that although the liposome was protected by all means through the preparation, 
it was still auto-oxidized during the sonication or by the air incubation. On the other 
hand, vitamin E provided sufficient protection to the liposomes through the sonication 
and air incubation. Comparing the scale of the TBARS results in Figure 15 and 16, we 
can see that without vitamin E, all the treatment groups had TBARS formation to around 
20 to 40 µM while the treatment groups within the vitamin E-containing liposomes were 
constrained within 1.5 to 4 µM of MDA equivalency.  
4.2.3. Pro-oxidant effect of α-tocopherol 
The previous research (Figures 14 and 16) was using 0.13 mg α-tocopherol per 18 mg 
lipid (0.072 mg/mg). Over the course of the research I tried different amounts of α-
tocopherol incorporated into liposomes, and interestingly the vitamin E protection from 
air induced oxidation was not proportional to its concentration. There was a statistically 
significant positive relationship between the TBARS generation during incubation and 
the amount of α-tocopherol (although statistical differences among the vitamin E groups 
were not evident using one-way ANOVA) (Figure 20). 
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Figure 20. TBARS generation in liposomes integrated with different amounts of α-
tocopherol. Liposomes were incubated with KPi buffer (pH 7.2, 50 mM) for one hour. 
Bars represent means  SEM (n=3 preparations). ab Different letters show significant 
differences by one-way ANOVA (post-hoc by Tukey’s HSD) at p<0.05). The inset shows 
the correlation between TBARS and increasing vitamin E content. **Statistically 
significant correlation at p < 0.01. 
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4.2.4 Effects of flavonoids and ascorbate on mitochondrial TBARS 
As the membrane contents in the two systems were measured differently (measured by 
lipid in liposomes and by protein in mitochondria), it was necessary to unify the two units 
in order to compare the amount of lipids that were subject to oxidation. According to 
Alberts et al. (123), the estimated overall weight ratio of protein-to-phospholipid in the 
mitochondrial membranes is around 2:1. With the liposomes, the final phospholipids 
concentration in the incubation was 1mg/ml. According to the ratio, 2 mg/ml protein of 
mitochondria suspension was equivalent to the liposome incubations as of lipid content.  
The original peroxide concentration (1 mM) was not able to induce significant oxidation 
in mitochondria in one hour (results not shown), perhaps due to the presence of 
peroxidases in mitochondria; therefore a higher concentration (5 mM) was used. The 
results from the TBARS test showed that the flavonoids alone gave significant protection 
against t-buOOH-induced TBARS (inhibiting by 27-40%), but there were still no 
synergistic effects by any flavonoids and ascorbate combination in protecting the 
mitochondria (Figure 21). The pattern that further addition of ascorbate in the presence of 
flavonoids exacerbated the oxidation was similar in both liposome (Figure 16 & 17) and 
mitochondria systems (Figure 21). The group treated with peroxide and ascorbate was 
considered to be the positive control and due to the small standard error in each group, it 
was significantly different from all the flavonoids treated groups except the group of rutin 
and ascorbate combination (with a trend of p=0.063).  
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Figure 21. Effects of different flavonoids and ascorbic acid on TBARS generation in 
mitochondria. Mitochondria (2 mg/ml) were incubated with KPi buffer (pH 7.2, 50 mM) 
for one hour (t-buOOH 5 mM, Asc – ascorbic acid 400 µM, Quer – quercetin, Catechin, 
Rutin and Cya - cyanidin 50 µM, n=4 preparations with at least double measurements for 
each preparation). Bars represent means  SEM. Analyzed by one-way ANOVA (post-
hoc by Tukey’s HSD) at p<0.05. All antioxidant treated groups (Group 4 - 12) had 
significant lower TBARS generation compared to the peroxide alone treated group 
(Group 3), while the TBARS values in the flavonoid + ascorbic acid combination groups 
were not different from groups treated with either antioxidants.  
Quercetin and catechin were also tested in experiments with mitochondria at 1 mg 
protein/ml (Figure 22). However the difference in the amount of incubated mitochondria 
did not affect the TBARS results. The quercetin or ascorbate alone inhibited significantly 
(47% and 37%), but their combined presence did not improve the inhibition.  
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Figure 22. Effects of quercetin, catechin and ascorbic acid on TBARS generation in 
mitochondria. Mitochondria (1 mg/ml) were incubated with KPi buffer (pH 7.2, 50 mM) 
for one hour (t-buOOH 5 mM, Asc – ascorbic acid 400 µM, Quer- quercetin 50 µM; Cat- 
catechin 50 µM. 
a-h
 Different letters show significant differences by one-way ANOVA 
(post-hoc by Tukey’s HSD) at p<0.05 (n=3 preparations, with 3 replicates per 
preparation). Bars represent means  SEM.  
4.3. Effects of ascorbate and flavonoids on α-tocopherol content and TBARS 
in rat liver mitochondria incubated with t-buOOH 
Experiments were conducted to measure both TBARS and the α-tocopherol content in 
samples of mitochondria after incubation with t-buOOH. In the TBARS results (Figure 
23), air incubation did not induce a statistical difference in mitochondrial oxidation level, 
but peroxide increased the TBARS formation significantly. In these experiments, only 
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catechin alone limited the oxidation significantly, although the inhibition by quercetin 
alone was close to significant (p = 0.085).  
 
Figure 23. Effects of ascorbic acid and flavonoids on t-buOOH-induced TBARS 
generation in rat liver mitochondria. Mitochondria (1 mg/ml) were incubated with KPi 
buffer (pH 7.2, 50 mM) for one hour (t-buOOH 5 mM, Asc – ascorbic acid 400 µM, Quer 
– quercetin 50 µM, Cat - catechin, 50 µM. abc Different letters show significant 
differences by one-way ANOVA (post-hoc by Tukey’s HSD) at p<0.05 (n=4 
preparations with one measurement per preparation). Bars represent mean  SEM. 
The concentrations of α-tocopherol in mitochondria after different treatments were 
measured by HPLC-MS/MS (Figure 24), and a closer look at one of the samples could be 
found in Appendix 1. Catechin’s involvement in the treatment did not affect the α-
tocopherol level, which was contrary to the protection effect observed in the TBARS 
results. Quercetin was more involved in the regeneration of α-tocopherol. Its presence 
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alone in the treatment did not deliver significant protection against α-tocopherol loss, but 
if ascorbate was also present in the treatment, there was a significant interaction (verified 
by two way ANOVA, p < 0.0001), maintaining the α-tocopherol at 5 times higher than 
the incubated mitochondria control group. The α-tocopherol level in the interaction group 
was not statistically different from the non-incubated mitochondria control group, p = 
0.084). The results therefore present a lack of consistency with the TBARS and vitamin E 
levels. 
 
Figure 24. Effects of ascorbic acid and flavonoids on α-tocopherol concentration in rat 
liver mitochondria after t-buOOH treatment. 
ab
 Different letters show significant 
differences by one-way ANOVA (post-hoc by Tukey’s HSD) at p<0.05. Bars represent 
mean  SEM. Results are obtained from the same samples as in Figure 23.  
55 
 
5. DISCUSSION 
5.1. Vitamin E protection from lipid peroxidation induced by vitamin C  
In these experiments, we tested the ability of vitamin E to prevent a pro-oxidant effect of 
ascorbate on lipid peroxidation. Ascorbate has long been observed to provoke lipid 
peroxidation in vitro (17, 19-21), perhaps because of its ability to participate in the 
Fenton reaction. When ascorbate and free metal ions are both present in the environment, 
the ascorbate would reduce metal ions, which would in turn reduce hydroperoxides to 
generate free radicals (the Fenton reaction). By using the highest quality of water and 
buffer salts, we minimised the presence of metal ions in the buffer and explored whether 
vitamin C alone was able to induce pro-oxidant effects. In Figures 10 to 12, vitamin C 
showed its ability to induce TBARS generation in both liposomes (without and with 
vitamin E) and mitochondria. Vitamin E-integrated liposomes (0.0028mg/mg) had an 
increase of 16% in TBARS values after being treated with 200 μM ascorbate and 39% 
with 400 μM ascorbate. The higher concentration of ascorbate was able to bring the 
difference to a significant level. The same concentrations of ascorbate increased the 
TBARS by 17% and 35% in mitochondria, which were both statistically different from 
the control group. The mitochondria contain endogenous metals which may contribute to 
the Fenton reaction, while with liposomes there may have been traces of catalytic metals. 
Alternatively, pre-formed hydroperoxides in the liposomes and mitochondria may have 
been reduced by ascorbate to produce peroxyl radicals that propagate lipid peroxidation. 
In 1999, Carr and Frei (29) reviewed the past in vivo studies on pro-oxidant effects of 
vitamin C and concluded that vitamin C does not act as a pro-oxidant.  Among the 44 in 
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vivo studies they reviewed, 38 showed a reduction in various biomarkers, 14 showed no 
change and only 6 showed an increase in oxidative damage after supplementation with 
vitamin C. They suggested that the pro-oxidant effects were from errors or metal 
contamination during the experiment. In an earlier review in 1996, Halliwell discussed 
the connection between in vitro studies and the possibility in vivo of elevated oxidative 
stress biomarkers and pro-oxidant effects of ascorbate (17). From the results of our 
studies, although it was not an in vivo experiment on human subjects, there still was some 
evidence against Frei’s theory that pro-oxidant effects are due to metal contamination 
(29). Both tested systems were maintained metal free, while the lipids were still oxidized 
by adding ascorbate. As a result, the oxidative stress induced by vitamin C in this 
research was different from the traditional pro-oxidant effects, which was performed by 
combination with metal ions. Another possibility raised by Chen (111) was that the 
adverse effects of vitamin C may be suppressed by vitamin E, indicating that the status of 
vitamin C as pro-oxidant or antioxidant depend on the concentration of vitamin E. 
The current experiments to test the ability of vitamin E in protecting against the pro-
oxidant activity of vitamin C were complicated by the very high levels of background 
oxidation in liposomes prepared in the absence of vitamin E. This oxidation occurred, 
presumably from sonication, despite efforts to decrease peroxidation by saturating the 
buffer with nitrogen. However it can be seen that 200 M ascorbate induced TBARS 
formation to a level of 8.5 M in liposomes without vitamin E (Figure 12), while in the 
presence of even a small amount of vitamin E the level of TBARS produced was only 0.8 
M (Figure 10). Also, in mitochondria, which contain vitamin E (Figure 11), the levels 
induced by 200-400 M ascorbate were only 1.0-1.1 nmol/mg (0.8 M in an equivalent 
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amount of lipid to the liposome experiments). It appears therefore that vitamin E provides 
at least partial protection to the membranes against the pro-oxidant effect of vitamin C. 
This protection would be consistent with the results of studies by Chen (111), who 
reported in rats that dietary vitamin E would ameliorate the oxidative stress induced by 
excessive vitamin C. Nevertheless, incubation with ascorbate also induced lipid 
peroxidation in mitochondria that had normal levels of vitamin E (Figure 11), showing 
that vitamin E does not provide complete protection. 
5.2. Antioxidant and pro-oxidant effects of vitamin E 
Comparing the TBARS levels of the control liposomes with and without vitamin E, the 
difference between them was almost 10 times. The liposomes without vitamin E suffered 
intensive initial oxidation, which could not be reduced back by adding any antioxidants 
or their combinations. On the other hand, even with the lowest integration amount of the 
vitamin E, it could prevent the initial oxidation and protect it against the peroxide. The 
experiments on liposomes with vitamin E are more biologically relevant since 
mitochondria are integrated with sufficient vitamin E in normal situations. In the aging 
process, the brain mitochondrial TBARS level of mice increased from 5.3 to 8.2 pmol/mg 
protein after 50 weeks (124) and in human Alzheimer’s disease, the mitochondria 
TBARS level is also increased within this range (125). These results demonstrate that in 
the worst case where the brain mitochondria are seriously damaged by oxidative stress, 
the oxidation level is far less than our mitochondria studies (Figures 21-23, TBARS level 
around nmol/mg). Although the component of mitochondria in different organs might 
vary, it is still clear that the protection on lipid membrane from vitamin E is not 
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sufficient. It requires further protection from other antioxidants in order to maintain 
normal physiological conditions. 
An interesting finding of the current studies with liposomes was a dose-dependent pro-
oxidant effect of vitamin E that increased TBARS formation during air-incubation of 
liposomes. Vitamin E has also previously been reported to have pro-oxidant effects (126, 
127). One possible explanation could be that the vitamin E radical, when it exists at 
higher concentrations in lipid membranes, may react with unsaturated lipids (LH) and 
lipid hydroperoxides (LOOH) to propagate lipid peroxidation (Figure 25) (126). 
 
Figure 25. Pro-oxidant mechanism of α-tocopherol (adapted from (126)) 
Redox (reduction-oxidation) reactions are complicated processes involving electron 
transfer or change in oxidation state by a molecule, atom, or ion. Whether a compound 
acts as an oxidant or reductant is relative, and it can act as both with different rates with 
different reactants. The radical of α-tocopherol is able to reduce the lipid peroxyl radical 
into lipid hydroperoxide (Figure 6), but it can also oxidize free lipid and lipid 
hydroperoxide (Figure 25).  With the presence of a stronger reductant, ascorbate in this 
case, the α-tocopherol radical can be consistently reduced and the redox balance is 
pushed forward to the reduction side. When stronger reductants or other radicals are not 
present, the α-tocopherol radical will react with the free lipid molecule, yielding lipid 
radical (reaction 1 in Figure 25 (126)), or react with lipid hydroperoxide, producing lipid 
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peroxyl radical (reaction 2 in Figure 25 (128)). The results in Figure 20 can be explained 
by this theory. With increasing amount of vitamin E integrated, the more competitive it is 
in rescuing free lipids (reducing lipid peroxyl radicals), and therefore more vitamin E 
radicals are formed. Due to limited exposure to strong oxidants in air incubation, the 
vitamin E radicals tend to deplete hydrogen atoms from free lipid molecules, resulting in 
higher TBARS formation.  
5.3. Flavonoid protection from lipid peroxidation induced by vitamin C in the 
absence of vitamin E 
The results in liposomes without vitamin E showed that, when quercetin was added into 
the solution without ascorbate it reduced the TBARS formation during air incubation, and 
together with ascorbate, quercetin was able to reduce the pro-oxidation effect of 
ascorbate to a significant level (Figure 12). The results indicate that quercetin can reverse 
the pro-oxidant effect of ascorbate, and together with ascorbate may rescue the liposome 
when vitamin E was insufficient in the membrane system. However, it might not occur in 
the normal situation as the mitochondria accumulate vitamin E and the level of vitamin E 
may preclude protection by quercetin. Therefore in situations of vitamin E deficiency, 
this effect of quercetin in protecting against pro-oxidant activities of ascorbate might be 
increasingly important. Moreover, incubation with ascorbate also induced lipid 
peroxidation in mitochondria that had normal levels of vitamin E (Figure 11). 
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5.4. Cooperation of flavonoids, vitamin C and vitamin E to inhibit lipid 
peroxidation 
When a stronger oxidant (t-buOOH) was present in the environment, vitamin C acted 
differently in the two tested lipid membrane systems. In liposomes (Figures 15 to 19), 
further addition of ascorbate after peroxide did not decrease the TBARS generation, 
indicating that either ascorbate alone or in combination with vitamin E was not able to 
ameliorate the oxidative stress on liposomes. However, in mitochondria (Figures 21 to 
23), ascorbate acted as radical scavenger and relieved the mitochondria from peroxide-
induced oxidative stress. The opposite behavior of vitamin C between the two systems 
could originate from the different composition of membrane structures. With 
mitochondria, many bio-active molecules embedded in the double layer membrane could 
enhance the antioxidant properties (eg. DHA reductase may help re-reduce vitamin C, 
while glutathione and peroxidases may help with antioxidant activities (10, 11)). 
Therefore, the antioxidants were more efficiently used and connected to each other in 
preventing the oxidative stress. 
Although multiple combinations of ascorbate, flavonoids and vitamin E at different 
concentrations were tested using the liposome model, no synergism was confirmed in 
these experiments. These results were against the initial hypothesis that the combination 
of the antioxidants was able to ameliorate the oxidation, indicating that vitamin E, 
ascorbate and flavonoids were not synergistically reacting with each other in reducing 
oxidative stress. In other research focusing on the synergism of these antioxidants, Dai et 
al. (2008) were able to identify the synergistic effects of ascorbate, α-tocopherol and 
polyphenols in other membrane system (SDS micelles with linoleic acid) (129). They 
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utilized kinetic studies and electron paramagnetic resonance spectroscopy to demonstrate 
that the antioxidant combination possessed synergistic antioxidative efficacy. This 
antioxidative efficacy was due to regeneration of α-tocopherol by polyphenols, which 
was subsequently regenerated by ascorbate. The reported synergism was observed by 
monitoring linoleic acid hydroperoxide formation over time and the consumption rate of 
the antioxidants, and the major tested polyphenols were catechin derivatives. The 
TBARS test, on the other hand, that we used in this research was a general test measuring 
reactive aldehydes (such as malondialdehyde) as the oxidation products of all 
polyunsaturated lipids. Three prevalent phospholipid molecules were selected to simulate 
the actual content in membrane systems. The antioxidants could be more reactive with 
simple fatty acids dispersed in micelles such as those used by Dai et al. (2008) than with 
phospholipid liposomes. Other differences in analytical techniques and target analytes 
could also contribute to this deviation in conclusions. 
In order to compare the two lipid systems in this research, we need to also compare the 
vitamin E concentration. As stated previously (in section 4.2.4), the rough comparison of 
the lipid content in the liposomal and mitochondrial membrane systems are equivalent at 
1 mg/ml (lipid concentration) liposomes and 2 mg/ml (protein concentration) of 
mitochondria (123). For vitamin E, 0.072 mg/mg (vitamin E/ total lipids) liposomal α-
tocopherol equals 0.2 nmol/mg lipid while the mitochondrial α-tocopherol content is 
around 1.3 nmol/mg total lipids (calculated based on Figure 24 control group data). In 
those conditions, no synergism of various antioxidants has been observed and the 
protection of vitamin E seems to be the dominant factor in reducing the oxidation. 
However, when the vitamin E level was manipulated to 0.0014 mg/mg lipid in liposomes, 
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quercetin (but not catechin or cyanidin) showed an additive protective effect (Figure 19). 
This might be due to the vitamin E being too low in concentration to cope with the 
oxidative stress and ascorbate and quercetin helped regenerate vitamin E or helped reduce 
the peroxide directly in the solution or membrane. This could be the reason that adding 
both ascorbate and quercetin did not decrease the TBARS formation in vitamin E rich 
liposomes (Figures 16 and 17) while they decreased the level in vitamin E-barren ones 
(Figures 15).  
Similar to the results on liposome with vitamin E integration, the administration of 
antioxidants to mitochondria failed to protect synergistically in TBARS tests. However, 
the flavonoids alone were able to protect the mitochondria from oxidation while the 
addition of ascorbate in the presence of flavonoid worsened the oxidation status (Figures 
21 - 23). 
5.5. Synergism of flavonoids and vitamin C in regenerating vitamin E 
The amount of α-tocopherol measured in the mitochondria (614 pmol/mg protein in 
mitochondria without incubation) was one third of the previously reported data of 2.12 
nmol/mg protein in rat liver mitochondria (121). The -tocopherol content, 0.055 
nmol/mg protein, was also reported in mitochondria from the previous research (110), 
although it was below the limits of detection in the current measurements. There were 
some differences in extraction method, HPLC mobile phase and mass spectrometry 
settings between the two studies. However, mitochondria from rat liver were used in both 
studies, making the results comparable. In both studies, the α-tocopherol content was the 
major component of the vitamin E in the mitochondrial membrane. (It should be noted 
63 
 
that commercial rodent lab chows are generally supplemented with α-tocopherol, so the 
amount observed in the mitochondria may be more than would be observed naturally.)  
Quercetin and ascorbate were not able to synergistically reduce the lipid oxidation status 
in mitochondria or liposomes; however, this antioxidant team interacted with each other 
in regenerating the mitochondrial α-tocopherol content. In Figure 24, either quercetin or 
ascorbate alone was not able to increase the α-tocopherol amount consumed by peroxide 
administration. Quercetin helped the α-tocopherol recovery, from 83.7 to 147.6 pmol/mg 
protein, although it wasn’t statistically significant. When combining the two antioxidants, 
the increase of α-tocopherol level was not simply an additive effect. The α-tocopherol 
level was promoted to 413.8 pmol/mg protein, which was recovered to the equivalent 
level as the non-treatment group. However, the change in α-tocopherol level did not 
affect the TBARS formation, indicating that the α-tocopherol level might not correlate to 
the mitochondrial oxidation level or a more complicated mechanism was involved.  
The major paradox in interpreting the results with mitochondria was the lack of 
correspondence between α-tocopherol concentration and TBARS formation. Being the 
major component of vitamin E in tissues, α-tocopherol would be expected to be 
negatively related to the oxidation status of the lipid membranes. However, comparing 
the results in Figure 23 and 24, from the same samples, no relationship was observed 
between TBARS and α-tocopherol. Three groups stood out against our hypothesis, the 
non-incubated group, catechin-treated group and quercetin+ascorbate-treated group. 
Comparing the non-incubated and incubated mitochondria, the α-tocopherol was 
consumed by 88% after one hour air incubation at 37
o
C, while the TBARS formation 
only increased by 4%. The cause of the α-tocopherol loss during incubation in KPi buffer 
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is unknown. The administration of 50 µM catechin did not protect α-tocopherol 
compared with the positive control group (with peroxide), while it ameliorated the 
oxidative stress on the mitochondria indicated by a 31% decrease in TBARS formation. 
The ascorbate-quercetin combination group did not show any protection against TBARS 
formation. However, it replenished the α-tocopherol content in mitochondria by nearly 
400% compared to the positive control group.  
One possible explanation for this phenomenon was that 5 mM peroxide induced acute 
oxidation in lipid membranes, whose reaction rate was higher than the regeneration of α-
tocopherol. In the beginning of the oxidation, the lipids were quickly oxidized and 
collaterally consumed a large amount of α-tocopherol in order to prevent this reaction. 
The α-tocopherol radicals regenerated later by ascorbate-quercetin could not reverse the 
TBARS formation within the lipid membranes. An extension of incubation time could 
examine this theory. Applying this hypothesis, the synergism comes slowly and could not 
save the mitochondria in the initial stage, while longer incubation time can induce more 
oxidative stress and the α-tocopherol cannot be regenerated in the groups other than the 
one receiving quercetin-ascorbate treatment.  
As reported previously, regeneration of vitamin E by vitamin C was found both in vitro 
(104) and in vivo (107). Vitamin E was also reported to be spared by flavonoids (112). In 
this research, however, the individual antioxidant was not able to regenerate the α-
tocopherol alone in the mitochondrial system. The combination of ascorbate and 
quercetin was the only efficient treatment in vitamin E regeneration, which was reported 
for the first time. 
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6. CONCLUSIONS 
The conclusions drawn from the research can be summarized as follows: 
 Ascorbate alone can induce a pro-oxidant effect in both the liposome and 
mitochondria systems, and the vitamin E content in both systems, although 
protective, does not completely prevent this event. For example, 200 μM and 400 
μM ascorbate induced 16% and 39% elevation in TBARS formation in liposomes 
containing 0.0028 mg/mg vitamin E. The same concentrations of ascorbate 
increased the TBARS by 17% and 35% in mitochondria.  
  The presence of quercetin inhibits the pro-oxidant effect of ascorbate in vitamin 
E-free liposomes. Quercetin at 50 μM was able to reduce the pro-oxidant effect of 
200 μM ascorbate in the plain liposomes.  
 The combination of ascorbate and quercetin can regenerate the α-tocopherol in the 
mitochondria while not decreasing the TBARS formation after one hour 
incubation at 37
oC, indicating that the α-tocopherol concentration was not 
correlated to the TBARS formation. 
Overall, based on the research data, ascorbate has pro-oxidative effect on both systems, 
which can be suppressed by quercetin but not completely by vitamin E. Among the tested 
flavonoids, only quercetin can synergistically react with ascorbate to regenerate α-
tocopherol while this interaction cannot rescue the mitochondria from oxidative damage.   
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7. FUTURE DIRECTIONS 
One technical question that needs to be addressed is that of multiple MS peaks observed 
for α-tocopherol. Although several possibilities were tested, the multi-peak problem of α-
tocopherol still persisted in the results. Also, in future studies the combined concentration 
of vitamin E and its metabolic products might better serve as the indicator of the 
oxidative stress. 
The pro-oxidant effects of vitamin C and E were not completely explored in the current 
research. The mechanism of pro-oxidant effects without free metal ions is unknown. 
Experiments with metal chelators may help identify any involvement of trace metals. 
Also, the ability of flavonoids to inhibit the pro-oxidant effect of ascorbate on 
mitochondria was not tested in the current studies. 
Another interesting line to follow is the relationship between the vitamin E concentration 
within the mitochondrial membranes and the oxidative status. The current results with 
liposomes indicate that they are correlated positively to each other, while it is commonly 
believed that the oxidative stress should decrease as the antioxidant concentration 
increases. 
As for the synergism of the different antioxidants, we tried the combinations of them in 
different concentrations while the exposure time was not well explored. The future study 
can focus on whether increasing the exposure time to the peroxide would reveal the 
ability of antioxidants to cooperate with each other by allowing time to further deplete 
vitamin E.  
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Finally in vivo studies can be another option for future directions. It will be important to 
determine the extent to which the interactions occur in vivo.  
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APPENDIX 1 
1. Multiple peaks in α-tocopherol  
The specific ionization and breaking pattern of each compound should generate a single 
signal, and the interaction between compounds and the HPLC column should be 
consistent throughout the analysis. However, in reality, there are many factors that can 
influence the specificity of the analysis. In analyzing the α-tocopherol content, there are 
three separate HPLC peaks with the characteristic parameters for α-tocopherol structure 
(left part in Figure 1AP). Several possible reasons can be applied to this phenomenon.  
1, Alpha-tocopherol can form a stable radical in the membranes with 1Da difference in 
molecular weight, and by forming the radical, the retention time is also shifted. This 
theory has been tested by adding a radical scavenger (2% BHT) into the sample. 
However, the multiple peaks remained in the results.  
2, Instead of capturing the specific daughter ion(s), the tandem mass spectrometry 
analysis (MS
2
) accumulates all the collision fragments and establishes a detailed picture 
of these fragments and their proportion. In comparing the MS
2
 results of the three peaks 
from the chromatogram, their fragments were different and so were their proportions. 
This indicated that the three portions of the samples were collided into different 
fragments, and ergo did not share the same chemical structure. The MS
2
 results of peak B 
in Figure 2AP showed three major fragments after collision, which were consistent with 
the three major fragments of standard α-tocopherol. The similarity confirmed that peak B 
was α-tocopherol extracted from mitochondria, in addition to the identical retention time. 
One of the fragments with mass over charge ratio of 239.1 is unique, and it can be 
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considered as the daughter ion to evaluate in pursuit of higher specificity of α-tocopherol 
detection in future analyses. 
 3, It has been reported that when α-tocopherol experiences intensive exposure to 
radicals, including peroxyl radicals, it is likely to be oxidized to -tocopherol-5,6-
quinone (tocored) (a). Tocored has a small difference in molecular weight compared to α-
tocopherol (0.04 Da). Assuming that its daughter ion has the dimethyl benzoquinone 
structure with a single charge (Figure 2AP), the mass over charge ratio for this molecule 
and its counterpart from α-tocopherol would have similar molecular weights (differing by 
0.04 Da), making them indistinguishable even using MS. The structural modification will 
lead to a shorter retention time as hydrophobicity increases, resulting in the earlier signal. 
This assumption is consistent with oxidation products described in research from Nagata 
et al (a), although they did not apply the collision cell in the mass spectrometry. 
However, this hypothesis suffers the problem of low tocored formation, which is more 
likely to be the product of γ-tocopherol instead of α-tocopherol. 
4, Another possibility is that the enantiomers of -tocopherol are separated by HPLC and 
generating signals at different time points. The possibility that the rat tissues contain 
different enantiomers is strengthened by the common supplementation of commercial 
rodent chows with -tocopherol, which may be a racemic mixture (all-rac). In order to 
testify this hypothesis, we can test whether all-rac -tocopherol as a standard would 
generate the same 3-peak result.  
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Figure 1AP. The bottom chromatogram is MS1 analysis of the mitochondria extract while the other 3 stacked graphs are MS2 
analysis on the three individual peaks. The highlighted peak is the target compound, as determined by comparison with the standards. 
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Figure 2AP. Tocored (A) and α-tocopherol (B) with their possible daughter ions 
2.  Gamma-tocopherol content determination using Mass spectrometry 
The HPLC parameters were the same as alpha-tocopherol and internal standard. The 
individualized MS parameters were as follow: corona discharge current, 4.0 uA; source 
temperature, 400°C; collision-activated collision gas (nitrogen) setting, 7 (arbitrary 
units); curtain gas (nitrogen) setting, 6; and nebulizer gas (air) setting, 10. MRM 
measurements with the transitions m/z+ 417.3/151.1 for γ-T (b). The Lower Limit of 
Quantification (LLOQ) of γ-tocopherol was determined as 100 pM, at which 
concentration yielded peak heights were 10 times higher than the noise baseline. We also 
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established the standard curve for γ-tocopherol from 100 pM to 250 pM, through which 
the γ-tocopherol concentration and the corresponding signal was linear. However, when 
testing the extractant from mitochondria, the results was not greater than the LLOQ, 
therefore this part of the result was not included in the thesis. 
 
Figure 3AP. The molecular structure of γ-tocopherol (A) and its daughter ions (B). Mass 
over charge ratio for B is 151.1. 
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